Dr Lalchandani Labs Ltd — Important, 16-02-2026: Company Update

The Company's Board has approved extending the closing date for its ongoing rights issue. This decision directly impacts shareholders by giving them more time to subscribe to the new shares being offered. For retail investors, this extension means a greater window to evaluate and participate in the company's capital raising efforts, which are crucial for funding future business operations and supporting growth initiatives. This step aims to ensure maximum participation in the rights issue.